Serious liver disease induced by infliximab

Infliximab, a chimeric monoclonal antibody that binds the tumor necrosis factor ? (TNF?), is used in the treatment of rheumatoid arthritis (RA) and Crohn’s disease (CD). Previous cases of significant secondary liver disease associated with infliximab treatment have been reported in patients with RA,...

Descripción completa

Detalles Bibliográficos
Autores Principales: Tobon,Gabriel J, Cañas,Carlos, Jaller,Juan-Jose, Restrepo, Juan-Carlos, Anaya, Juan-Manuel
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Springer Nature 2006
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/25955
https://doi.org/10.1007/s10067-005-0169-y